Philips and Ibex Medical Analytics Collaborate to Promote AI-Powered Digital Pathology to Hospitals
Written by AZoRoboticsApr 9 2021
Royal Philips, a global leader in health technology, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, today announced a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
The combination of Philips digital pathology solution (Philips IntelliSite Pathology Solution) and Ibex’s Galen™ AI-powered cancer diagnostics platform, currently in clinical use in Europe and the Middle East, empowers pathologists to generate objective, reproducible results, increase diagnostic confidence, and enable the productivity and efficiency improvements needed to cope with ever-increasing demand for pathology-based diagnostics.
Philips e Ibex Medical Analytics se unen para acelerar la patología digital impulsada por IA
europapress.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europapress.es Daily Mail and Mail on Sunday newspapers.
Philips e Ibex Medical Analytics se unen para acelerar la patología digital con inteligencia artificial
infosalus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infosalus.com Daily Mail and Mail on Sunday newspapers.
Royal Philips: Philips and Ibex Medical Analytics team to accelerate adoption of AI-powered digital pathology
Philips and Ibex Medical Analytics cooperate to globally commercialize clinically proven, AI-powered digital pathology solutions
Combination of Philips digital pathology solutions and Ibex s AI-powered Galen platform has improved reporting efficiency by 27%, driven 37% productivity gains, and improved consistency and accuracy to enhance diagnostic confidence
Collaboration furthers Philips commitment to integrated diagnostics providing a clear path to precision diagnosis
Amsterdam, The Netherlands and Tel Aviv, Israel -
Royal Philips, a pioneer in artificial intelligence) and Ibex s Galen AI-powered cancer diagnostics platform [1], currently in clinical use in Europe and the Middle East, empowers pathologists to generate objective, reproducible results, increase diagnostic confidence, and enable the productivity and efficiency improvements needed to cope with ever-incr